| Kimberly Marie Gibbons, MA, CCC-SLP | |
|
2425 Foxboro Ave, Akron, OH 44305-2220 | |
| (330) 631-5678 | |
| Not Available |
| Full Name | Kimberly Marie Gibbons |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2425 Foxboro Ave, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023416922 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP7694 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Marie Gibbons, MA, CCC-SLP 2425 Foxboro Ave, Akron, OH 44305-2220 Ph: (330) 631-5678 | Kimberly Marie Gibbons, MA, CCC-SLP 2425 Foxboro Ave, Akron, OH 44305-2220 Ph: (330) 631-5678 |
News Archive
Obesity is an independent predictor of inadequate bowel preparation at colonoscopy, and the presence of additional risk factors further increases the likelihood of a poorly cleansed colon, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.
The Partnership at Drugfree.org, in cooperation with the Boston University School of Public Health, announced today that Join Together has become part of the 25-year-old nonprofit organization based in New York City.
NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, announced that the University of Southern California (USC) has licensed NextBio Enterprise for research use by students and faculty. The University plans to promote use of the NextBio research platform campus-wide beginning in August.
Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an international Phase III clinical trial to evaluate the efficacy and safety of florbetaben (BAY 94-9172) PET imaging in the detection of beta-Amyloid plaques in the brain, which are a pathological hallmark of Alzheimer's disease.
The "full details of how the money will be spent" has not yet been released, but the guide said the initiative would aim to increase "access to products such as fertilisers and new technology, including agriculture biotechnology," the Financial Times reports.
› Verified 2 days ago
Michele Y Gunther, S.P.L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 640 W Market St, Akron, OH 44303 Phone: 330-762-5425 | |
Jamie Blaylock, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 450 Vernon Odom Blvd, Akron, OH 44307 Phone: 330-376-0153 | |
Kristin Weaver, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 640 W Market St, Akron, OH 44303 Phone: 330-762-5425 | |
Mrs. Elizabeth Kinzig, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Wyant Rd, Akron, OH 44313 Phone: 330-836-7953 | |
Mrs. Andrea P. Brewer, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 181 Polsky Building, Akron, OH 44325 Phone: 330-972-8189 Fax: 330-972-7884 | |
Mary Mariani-walker, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1199 Vernon Odom Blvd, Akron, OH 44307 Phone: 330-873-3396 |